Canadian prescription drug costs surpass $18 billion

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 10, 2005, Pages 1323-1324

  Morgan, Steve ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIMETIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; SULFANILAMIDE;

COST CONTROL; DRUG COST; DRUG DESIGN; DRUG INDUSTRY; NOTE; PRESCRIPTION;

EID: 19744365044     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.050444     Document Type: Note

References (4)

1. Canadian Institute for Health Information. Drug expenditure in Canada 1985 to 2004. Ottawa: The Institute; 2005.
2. Canada. Report concerning the manufacture, distribution and sale of drugs. Ottawa: Department of Justice; 1963.
3. Canada. Report of the Commission of Inquiry on the Pharmaceutical Industry. Ottawa: Supply and Services Canada; 1985.
4. Morgan SG. Drug spending in Canada: recent trends and causes. Med Care 2004;42(7):635-42.